Quinoxalines useful as cytoprotective agents
US10730843B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Inventor
Key dates
| Filing date | Jun 20, 2019 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Jun 20, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.